NHS Genomic Medicine Service - Most Suitable Provider Process

{
  "id": "067976-2025",
  "tag": [
    "award",
    "contract"
  ],
  "bids": {
    "statistics": [
      {
        "id": "1",
        "value": 3,
        "measure": "bids",
        "relatedLot": "1"
      },
      {
        "id": "2",
        "value": 3,
        "measure": "bids",
        "relatedLot": "2"
      },
      {
        "id": "3",
        "value": 3,
        "measure": "bids",
        "relatedLot": "3"
      },
      {
        "id": "4",
        "value": 3,
        "measure": "bids",
        "relatedLot": "4"
      },
      {
        "id": "5",
        "value": 3,
        "measure": "bids",
        "relatedLot": "5"
      },
      {
        "id": "6",
        "value": 3,
        "measure": "bids",
        "relatedLot": "6"
      },
      {
        "id": "7",
        "value": 3,
        "measure": "bids",
        "relatedLot": "7"
      }
    ]
  },
  "date": "2025-10-23T17:00:36+01:00",
  "ocid": "ocds-h6vhtk-0565e9",
  "buyer": {
    "id": "GB-FTS-118033",
    "name": "NHS England"
  },
  "awards": [
    {
      "id": "067976-2025-1",
      "title": "Lot 1 - NHS North-West GMS",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-18796",
          "name": "Manchester University NHS Foundation Trust"
        }
      ],
      "relatedLots": [
        "1"
      ]
    },
    {
      "id": "067976-2025-2",
      "title": "Lot 2 - NHS North-East and Yorkshire GMS",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-78899",
          "name": "The Newcastle upon Tyne Hospitals NHS Foundation Trust"
        }
      ],
      "relatedLots": [
        "2"
      ]
    },
    {
      "id": "067976-2025-3",
      "title": "Lot 3 NHS Central and South GMS",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-1009",
          "name": "Birmingham Women’s and Children’s NHS Foundation Trust"
        }
      ],
      "relatedLots": [
        "3"
      ]
    },
    {
      "id": "067976-2025-4",
      "title": "Lot 4 NHS East GMS",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-6625",
          "name": "Cambridge University Hospitals NHS Foundation Trust"
        }
      ],
      "relatedLots": [
        "4"
      ]
    },
    {
      "id": "067976-2025-5",
      "title": "Lot 5 NHS South-West GMS",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-12898",
          "name": "North Bristol NHS Trust"
        }
      ],
      "relatedLots": [
        "5"
      ]
    },
    {
      "id": "067976-2025-6",
      "title": "Lot 6 NHS North Thames GMS",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-95413",
          "name": "Great Ormond Street Hospital for Children NHS Foundation Trust"
        }
      ],
      "relatedLots": [
        "6"
      ]
    },
    {
      "id": "067976-2025-7",
      "title": "Lot 7 NHS South-East GMS",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-21063",
          "name": "Guy's and St Thomas' NHS Foundation Trust"
        }
      ],
      "relatedLots": [
        "7"
      ]
    }
  ],
  "tender": {
    "id": "C368833",
    "lots": [
      {
        "id": "1",
        "title": "Lot 1 – NHS North-West GMS",
        "status": "cancelled",
        "options": {
          "description": "Options to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period."
        },
        "hasOptions": true,
        "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>*\tOrganisational leadership, governance and partnership arrangements;<br/>*\tDelivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>*\tLaboratory operating model;<br/>*\tClinical function: cancer genomics;<br/>*\tClinical function: rare disease;<br/>*\tClinical function: population health;<br/>*\tPromotion of and supporting and leading where relevant science, research and / or innovation;<br/>*\tTransformation and Service Improvement;<br/>*\tPeople – workforce, education and training; and<br/>*\tData and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Most suitable provider process with regard to the key Criteria",
              "type": "cost",
              "description": "100"
            }
          ]
        }
      },
      {
        "id": "2",
        "title": "Lot 2 – NHS North-East and Yorkshire GMS",
        "status": "cancelled",
        "options": {
          "description": "Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period"
        },
        "hasOptions": true,
        "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>*\tOrganisational leadership, governance and partnership arrangements;<br/>*\tDelivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>*\tLaboratory operating model;<br/>*\tClinical function: cancer genomics;<br/>*\tClinical function: rare disease;<br/>*\tClinical function: population health;<br/>*\tPromotion of and supporting and leading where relevant science, research and / or innovation;<br/>*\tTransformation and Service Improvement;<br/>*\tPeople – workforce, education and training; and<br/>*\tData and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Most suitable provider process with regard to the key Criteria",
              "type": "cost",
              "description": "100"
            }
          ]
        }
      },
      {
        "id": "3",
        "title": "Lot 3 – NHS Central and South GMS",
        "status": "cancelled",
        "options": {
          "description": "Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period"
        },
        "hasOptions": true,
        "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>*\tOrganisational leadership, governance and partnership arrangements;<br/>*\tDelivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>*\tLaboratory operating model;<br/>*\tClinical function: cancer genomics;<br/>*\tClinical function: rare disease;<br/>*\tClinical function: population health;<br/>*\tPromotion of and supporting and leading where relevant science, research and / or innovation;<br/>*\tTransformation and Service Improvement;<br/>*\tPeople – workforce, education and training; and<br/>*\tData and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Most suitable provider process with regard to the key Criteria",
              "type": "cost",
              "description": "100"
            }
          ]
        }
      },
      {
        "id": "4",
        "title": "Lot 4 – NHS East GMS",
        "status": "cancelled",
        "options": {
          "description": "Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period"
        },
        "hasOptions": true,
        "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>*\tOrganisational leadership, governance and partnership arrangements;<br/>*\tDelivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>*\tLaboratory operating model;<br/>*\tClinical function: cancer genomics;<br/>*\tClinical function: rare disease;<br/>*\tClinical function: population health;<br/>*\tPromotion of and supporting and leading where relevant science, research and / or innovation;<br/>*\tTransformation and Service Improvement;<br/>*\tPeople – workforce, education and training; and<br/>*\tData and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Most suitable provider process with regard to the key Criteria",
              "type": "cost",
              "description": "100"
            }
          ]
        }
      },
      {
        "id": "5",
        "title": "Lot 5 – NHS South-West GMS",
        "status": "cancelled",
        "options": {
          "description": "Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period"
        },
        "hasOptions": true,
        "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>*\tOrganisational leadership, governance and partnership arrangements;<br/>*\tDelivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>*\tLaboratory operating model;<br/>*\tClinical function: cancer genomics;<br/>*\tClinical function: rare disease;<br/>*\tClinical function: population health;<br/>*\tPromotion of and supporting and leading where relevant science, research and / or innovation;<br/>*\tTransformation and Service Improvement;<br/>*\tPeople – workforce, education and training; and<br/>*\tData and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Most suitable provider process with regard to the key Criteria",
              "type": "cost",
              "description": "100"
            }
          ]
        }
      },
      {
        "id": "6",
        "title": "Lot 6 – NHS North Thames GMS",
        "status": "cancelled",
        "options": {
          "description": "Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period"
        },
        "hasOptions": true,
        "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>*\tOrganisational leadership, governance and partnership arrangements;<br/>*\tDelivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>*\tLaboratory operating model;<br/>*\tClinical function: cancer genomics;<br/>*\tClinical function: rare disease;<br/>*\tClinical function: population health;<br/>*\tPromotion of and supporting and leading where relevant science, research and / or innovation;<br/>*\tTransformation and Service Improvement;<br/>*\tPeople – workforce, education and training; and<br/>*\tData and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Most suitable provider process with regard to the key Criteria",
              "type": "cost",
              "description": "100"
            }
          ]
        }
      },
      {
        "id": "7",
        "title": "Lot 7 – NHS South-East GMS",
        "status": "cancelled",
        "options": {
          "description": "Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period"
        },
        "hasOptions": true,
        "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>*\tOrganisational leadership, governance and partnership arrangements;<br/>*\tDelivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>*\tLaboratory operating model;<br/>*\tClinical function: cancer genomics;<br/>*\tClinical function: rare disease;<br/>*\tClinical function: population health;<br/>*\tPromotion of and supporting and leading where relevant science, research and / or innovation;<br/>*\tTransformation and Service Improvement;<br/>*\tPeople – workforce, education and training; and<br/>*\tData and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Most suitable provider process with regard to the key Criteria",
              "type": "cost",
              "description": "100"
            }
          ]
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKD"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "2",
        "relatedLot": "2",
        "deliveryAddresses": [
          {
            "region": "UKC"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "3",
        "relatedLot": "3",
        "deliveryAddresses": [
          {
            "region": "UKG"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "4",
        "relatedLot": "4",
        "deliveryAddresses": [
          {
            "region": "UKH"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "5",
        "relatedLot": "5",
        "deliveryAddresses": [
          {
            "region": "UKK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "6",
        "relatedLot": "6",
        "deliveryAddresses": [
          {
            "region": "UKI"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "7",
        "relatedLot": "7",
        "deliveryAddresses": [
          {
            "region": "UKJ"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      }
    ],
    "title": "NHS Genomic Medicine Service - Most Suitable Provider Process",
    "status": "complete",
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "This is a notice of intention to make an award in respect of the NHS Genomic Medicine Service pursuant to the Most Suitable Provider (MSP) Process for the NHS Genomic Medicine Service (NHS GMS). For the avoidance of doubt, this is an intention to award notice. A notice of the confirmation of the award of each contract will be issued once they are signed.<br/><br/>Pursuant to the NHS GMS contracts, provider are to provide the following functions: <br/>• Organisational leadership, governance and partnership arrangements;<br/>• Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>• Laboratory operating model;<br/>• Clinical function: cancer genomics;<br/>• Clinical function: rare disease;<br/>• Clinical function: population health;<br/>• Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>• Transformation and Service Improvement;<br/>• People – workforce, education and training; and<br/>• Data and digital",
    "classification": {
      "id": "85100000",
      "scheme": "CPV",
      "description": "Health services"
    },
    "procurementMethod": "limited",
    "mainProcurementCategory": "services",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by Tuesday 4th November 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "D_OUTSIDE_SCOPE",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
        "description": "The procurement falls outside the scope of application of the directive"
      }
    ]
  },
  "parties": [
    {
      "id": "GB-FTS-118033",
      "name": "NHS England",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKE",
        "locality": "Leeds",
        "postalCode": "LS1 4AP",
        "countryName": "United Kingdom",
        "streetAddress": "7&8 Wellington Place"
      },
      "details": {
        "url": "https://www.england.nhs.uk//",
        "buyerProfile": "https://www.england.nhs.uk//",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS England"
      },
      "contactPoint": {
        "name": "Anna Salt",
        "email": "anna.salt@nhs.net"
      }
    },
    {
      "id": "GB-FTS-18796",
      "name": "Manchester University NHS Foundation Trust",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKD3",
        "locality": "Manchester",
        "countryName": "United Kingdom"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Manchester University NHS Foundation Trust"
      }
    },
    {
      "id": "GB-FTS-78899",
      "name": "The Newcastle upon Tyne Hospitals NHS Foundation Trust",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKC2",
        "locality": "Newcastle",
        "countryName": "United Kingdom"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "The Newcastle upon Tyne Hospitals NHS Foundation Trust"
      }
    },
    {
      "id": "GB-FTS-1009",
      "name": "Birmingham Women’s and Children’s NHS Foundation Trust",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKG3",
        "locality": "Birmingham",
        "countryName": "United Kingdom"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Birmingham Women’s and Children’s NHS Foundation Trust"
      }
    },
    {
      "id": "GB-FTS-6625",
      "name": "Cambridge University Hospitals NHS Foundation Trust",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKH1",
        "locality": "Cambridge",
        "countryName": "United Kingdom"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Cambridge University Hospitals NHS Foundation Trust"
      }
    },
    {
      "id": "GB-FTS-12898",
      "name": "North Bristol NHS Trust",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKK1",
        "locality": "Bristol",
        "countryName": "United Kingdom"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "North Bristol NHS Trust"
      }
    },
    {
      "id": "GB-FTS-95413",
      "name": "Great Ormond Street Hospital for Children NHS Foundation Trust",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKI3",
        "locality": "London",
        "countryName": "United Kingdom"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Great Ormond Street Hospital for Children NHS Foundation Trust"
      }
    },
    {
      "id": "GB-FTS-21063",
      "name": "Guy's and St Thomas' NHS Foundation Trust",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKI3",
        "locality": "London",
        "countryName": "United Kingdom"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Guy's and St Thomas' NHS Foundation Trust"
      }
    },
    {
      "id": "GB-FTS-141301",
      "name": "NHS Arden and Greater East Midlands Commissioning Support Unit",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Derby",
        "postalCode": "DE1 3QT",
        "countryName": "United Kingdom",
        "streetAddress": "Cardinal Square, 10 Nottingham Road"
      },
      "details": {
        "url": "https://www.ardengemcsu.nhs.uk/"
      },
      "identifier": {
        "legalName": "NHS Arden and Greater East Midlands Commissioning Support Unit"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "067976-2025-1",
      "title": "Lot 1 - NHS North-West GMS",
      "value": {
        "amount": 5175000000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "067976-2025-1",
      "dateSigned": "2025-10-21T00:00:00+01:00"
    },
    {
      "id": "067976-2025-2",
      "title": "Lot 2 - NHS North-East and Yorkshire GMS",
      "value": {
        "amount": 5175000000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "067976-2025-2",
      "dateSigned": "2025-10-21T00:00:00+01:00"
    },
    {
      "id": "067976-2025-3",
      "title": "Lot 3 NHS Central and South GMS",
      "value": {
        "amount": 5175000000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "067976-2025-3",
      "dateSigned": "2025-10-21T00:00:00+01:00"
    },
    {
      "id": "067976-2025-4",
      "title": "Lot 4 NHS East GMS",
      "value": {
        "amount": 5175000000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "067976-2025-4",
      "dateSigned": "2025-10-21T00:00:00+01:00"
    },
    {
      "id": "067976-2025-5",
      "title": "Lot 5 NHS South-West GMS",
      "value": {
        "amount": 5175000000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "067976-2025-5",
      "dateSigned": "2025-10-21T00:00:00+01:00"
    },
    {
      "id": "067976-2025-6",
      "title": "Lot 6 NHS North Thames GMS",
      "value": {
        "amount": 5175000000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "067976-2025-6",
      "dateSigned": "2025-10-21T00:00:00+01:00"
    },
    {
      "id": "067976-2025-7",
      "title": "Lot 7 NHS South-East GMS",
      "value": {
        "amount": 5175000000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "067976-2025-7",
      "dateSigned": "2025-10-21T00:00:00+01:00"
    }
  ],
  "description": "This is a Provider Selection Regime (PSR) intention to award notice. This intention to award notice is subject to Regulation 10(7) of the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023  do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight on Tuesday 4th November 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.<br/>Written representations should be sent to england.genomics@nhs.net, ensuring the following details are referenced:<br/>Project reference: C368833<br/>Project title: NHS Genomic Medicine Service - Most Suitable Provider process<br/>This decision has been made as per NHS England governance processes, by the Commercial Executive Group on 14th October 2025 and the National Commissioning Group on 21st October 2025. No conflicts of Interest were identified amongst decision-makers.<br/>Each of the 5 key criteria were balanced with equal priority and considered on this basis and consideration was given to the basic selection criteria. Following provider assessments, it was agreed that the providers are the only providers capable of meeting the service specifications and requirements of the NHS GMS in full.<br/><br/>Additional CPV codes include:<br/>85145000-7 (Services provided by medical laboratories),<br/>85148000-8 (Medical analysis services)<br/>85111810-1 (Blood analysis services)<br/>85121200-5 (Medical specialist services)<br/>85140000-2 (Miscellaneous health services)",
  "initiationType": "tender"
}

{
  "id": "042969-2025",
  "tag": [
    "planning"
  ],
  "date": "2025-07-24T17:52:49+01:00",
  "ocid": "ocds-h6vhtk-0565e9",
  "buyer": {
    "id": "GB-FTS-118033",
    "name": "NHS England"
  },
  "tender": {
    "id": "C368833",
    "lots": [
      {
        "id": "1",
        "title": "Lot 1 – North-West NHS GMS",
        "status": "planned",
        "description": "Please note that the contract value indicated in this notice is based on the values from year 2024/2025 for a maximum contract period of up to 10 years. Therefore, this contract value is an estimation only at this stage and is subject to change."
      },
      {
        "id": "2",
        "title": "Lot 2 – North-East and Yorkshire NHS GMS",
        "status": "planned",
        "description": "Please note that the contract value indicated in this notice is based on the values from year 2024/2025 for a maximum contract period of up to 10 years. Therefore, this contract value is an estimation only at this stage and is subject to change."
      },
      {
        "id": "3",
        "title": "Lot 3 – Central and South NHS GMS",
        "status": "planned",
        "description": "Please note that the contract value indicated in this notice is based on the values from year 2024/2025 for a maximum contract period of up to 10 years. Therefore, this contract value is an estimation only at this stage and is subject to change."
      },
      {
        "id": "4",
        "title": "Lot 4 – East NHS GMS",
        "status": "planned",
        "description": "Please note that the contract value indicated in this notice is based on the values from year 2024/2025 for a maximum contract period of up to 10 years. Therefore, this contract value is an estimation only at this stage and is subject to change."
      },
      {
        "id": "5",
        "title": "Lot 5 – South-West NHS GMS",
        "status": "planned",
        "description": "Please note that the contract value indicated in this notice is based on the values from year 2024/2025 for a maximum contract period of up to 10 years. Therefore, this contract value is an estimation only at this stage and is subject to change."
      },
      {
        "id": "6",
        "title": "Lot 6 – North Thames NHS GMS",
        "status": "planned",
        "description": "Please note that the contract value indicated in this notice is based on the values from year 2024/2025 for a maximum contract period of up to 10 years. Therefore, this contract value is an estimation only at this stage and is subject to change."
      },
      {
        "id": "7",
        "title": "Lot 7 – South-East NHS GMS",
        "status": "planned",
        "description": "Please note that the contract value indicated in this notice is based on the values from year 2024/2025 for a maximum contract period of up to 10 years. Therefore, this contract value is an estimation only at this stage and is subject to change."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKD"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "2",
        "relatedLot": "2",
        "deliveryAddresses": [
          {
            "region": "UKC"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "3",
        "relatedLot": "3",
        "deliveryAddresses": [
          {
            "region": "UKF"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "4",
        "relatedLot": "4",
        "deliveryAddresses": [
          {
            "region": "UKH"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "5",
        "relatedLot": "5",
        "deliveryAddresses": [
          {
            "region": "UKK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "6",
        "relatedLot": "6",
        "deliveryAddresses": [
          {
            "region": "UKI"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "7",
        "relatedLot": "7",
        "deliveryAddresses": [
          {
            "region": "UKJ"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      }
    ],
    "title": "NHS Genomic Medicine Service - Most Suitable Provider Process",
    "value": {
      "amount": 3850000000,
      "currency": "GBP"
    },
    "status": "planned",
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "This is an Intended Approach Notice to award contracts using the Most Suitable Provider (MSP) Process for the NHS Genomic Medicine Service (NHS GMS).<br/><br/>The draft service specification (the Specification) published as part of this MSP process defines the requirements, responsibilities, expertise and interactions of an integrated system of functions which must be provided cohesively as a complete set. The complete set of functions is made up of:<br/>•\tOrganisational leadership, governance and partnership arrangements; <br/>•\tDelivery of genomic testing outlined in the National Genomic Test Directory (NGTD); <br/>•\tLaboratory operating model; <br/>•\tClinical function: cancer genomics; <br/>•\tClinical function: rare disease; <br/>•\tClinical function: population health; <br/>•\tPromotion of and supporting and leading where relevant science, research and / or innovation; <br/>•\tTransformation and Service Improvement;  <br/>•\tPeople – workforce, education and training; and<br/>•\tData and digital<br/><br/>Providers should only respond to this Notice if they can demonstrate their experience, expertise, capability and readiness to meet the requirements of each of the functions set out in the Specification. <br/><br/>The Commissioner expects, based on knowledge accrued from legacy service provision and a period of market engagement, that only NHS organisations will be able to meet the requirements for the complete set of functions of the NHS GMS as set out in the Specification, and are therefore under consideration to be the Most Suitable Providers. The reasons for this include:<br/>•\tThe services being procured require to be integrated with existing NHS operations including shared IT systems, clinical pathways and a range of NHS-commissioned clinical services <br/>•\tThe services being procured require NHS clinical governance structures and direct NHS clinical care and safety oversight;<br/>•\tThe services being procured require seamless integration into existing NHS patient care pathways, data sharing and accountability; and<br/>•\tThe services being procured are intended to be delivered by existing NHS partners to support collaboration with system partners and the delivery of cross-organisational objectives and joint programmes aligned to national strategies.<br/><br/>The Commissioner's assessment of each potential provider's submission will take into account the basic selection criteria and the following key criteria: <br/>•\tQuality and innovation;<br/>•\tValue;<br/>•\tIntegration, collaboration and service sustainability;<br/>•\tImproving access, reducing health inequalities and facilitating choice; and<br/>•\tSocial value.<br/>The Commissioner's assessment will be on a pass/fail basis.<br/><br/>If you believe your organisation can provide the full set of requirements of the NHS GMS, please register on the e-Tendering portal at  https://health-family.force.com/s/Welcome against project reference C368833 to access the MSP documentation and submit your response.<br/>The deadline for submitting completed Expression of Interest Questionnaires and Declarations is 12pm, midday, on Thursday 21st August 2025.<br/>It is anticipated that provider assessments will be completed between 27th August and 17th September 2025.",
    "communication": {
      "atypicalToolUrl": "https://health-family.force.com/s/Welcome",
      "futureNoticeDate": "2025-09-18T00:00:00+01:00"
    },
    "classification": {
      "id": "85100000",
      "scheme": "CPV",
      "description": "Health services"
    },
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-FTS-118033",
      "name": "NHS England",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKE",
        "locality": "Leeds",
        "postalCode": "LS1 4AP",
        "countryName": "United Kingdom",
        "streetAddress": "7&8 Wellington Place"
      },
      "details": {
        "url": "https://www.england.nhs.uk//",
        "buyerProfile": "https://www.england.nhs.uk//",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS England"
      },
      "contactPoint": {
        "email": "anna.salt@nhs.net"
      }
    }
  ],
  "language": "en",
  "description": "The NHS GMS was established by NHS England in 2018 to support standardised, high quality and equitable access to Genomic Medicine across the NHS in England and will be pivotal to ensuring that the NHS is the best-placed system in the world to harness advances in genomic science coupled with similar advances in data, AI and analytics. <br/><br/>To look to the future and to build on the commitments in the Accelerating Genomic Medicine in the NHS strategy, and to support the scale of change set out in the NHS 10 Year Health Plan for England and the Life Sciences Sector Plan, transformational change is now needed to deliver a clinical NHS GMS that is fit for purpose. From sickness to prevention, analogue to digital and hospital to community, the NHS GMS will play a key role in reshaping the way in which the NHS delivers care.<br/><br/>Each Lead Provider commissioned by NHS England to deliver the NHS GMS in a designated Lot will need to provide the requirements of the full set of functions as set out in the Specification. This will require each Provider to:<br/><br/>•\tStrategically work with commissioners, Providers and other stakeholders to maximise the benefits that genomics can deliver for patients, their families and carers, and communities more broadly; <br/>•\tDrive new models of care informed by the use of genomics and changes in care pathways across rare diseases, cancer genomics, more common disease and in approaches to population health, underpinned by operational and clinical guidance and new services, including a new Genomics Population Health Service; <br/>•\tProvide a comprehensive and equitable genomic testing offer with adoption of new advances and technologies linked to precision and ATMP medicines; <br/>•\tAccelerate the use of automation and industrialisation in laboratory services, to create efficiencies, drive productivity, enable consolidation, deliver high throughput testing and reduce Turnaround Times; <br/>•\tFurther develop the genomic data and digital infrastructure, enabling genomic and clinical data to be connected in near real time, and ensuring data can be used for multiple purposes; <br/>•\tDevelop its multispecialty workforce to continue to mainstream genomics and to make genomics commonplace in the NHS through normalising its use and application across its geography; and <br/>•\tEnable innovation, research and excellence in genomics, while generating and building evidence to adopt innovation into commissioning and supporting patients to access clinical trials.   <br/><br/>Please note that the contract value indicated in this notice is based on the values from year 2024/2025 for a maximum contract period of up to 10 years. Therefore, this contract value is an estimation only at this stage and is subject to change.<br/><br/>This is a Provider Selection Regime (PSR) intended approach notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award.<br/>The intention is to award contracts using the Most Suitable Provider Process and the award decisions will be made by National Commissioning Group, Chaired by the NHS England National Director of Specialised Commissioning, and by the NHS England Commercial Executive Group, Chaired by the NHS England Chief Financial Officer.<br/><br/>Additional CPV codes include:<br/>85145000-7 (Services provided by medical laboratories), <br/>85148000-8 (Medical analysis services)<br/>85111810-1 (Blood analysis services)<br/>85121200-5 (Medical specialist services) <br/>85140000-2 (Miscellaneous health services)",
  "initiationType": "tender"
}